Sunshine Biopharma Inc. (SBFM) › Operating Cash FlowSunshine Biopharma Inc. (SBFM) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$348.3K2011: -$297.3K2012: -$393.1K2013: -$564.4K2014: -$538.6K2015: -$867.6K2016: -$314.2K2017: -$543.5K2018: -$512.8K2019: -$495.8K2020: -$657.3K2021: -$1.83M2022: -$5.25M2023: -$8.78M2024: -$12.52M2025: -$5.33M-$5.33M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$5.33M+57.4%2024-$12.52M-42.7%2023-$8.78M-67.2%2022-$5.25M-186.9%2021-$1.83M-178.3%2020-$657.3K-32.6%2019-$495.8K+3.3%2018-$512.8K+5.7%2017-$543.5K-73.0%2016-$314.2K+63.8%2015-$867.6K-61.1%2014-$538.6K+4.6%2013-$564.4K-43.6%2012-$393.1K-32.2%2011-$297.3K+14.6%2010-$348.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share